The Senate last night voted 85-7 to pass an $857 billion spending package, which includes bills that would fund the departments of Health and Human Services, Defense and Labor for fiscal year 2019. The bill would provide a $2.3 billion increase for HHS from 2018. Among other provisions, the bill would provide $3.7 billion, an increase of $147 million, to continue combatting the opioid epidemic; $325 million, an increase of $10 million, for the Children’s Hospitals Graduate Medical Education program; $319 million, an increase of $28 million, for rural health care programs; and $3.5 billion, an increase of $113 million, to help communities prepare for, respond to, and recover from public health and medical disasters such as influenza, Ebola, Zika and natural disasters. It also would increase funding for the National Institutes of Health by $2 billion. In addition the bill includes a provision, as urged by the AHA, to address the out-of-control cost of prescription drugs by providing funding to enable HHS to require disclosure of drug pricing information in direct-to-consumer advertising. The Senate and House are expected to enter into conference negotiations to reconcile their bills. Current funding runs out Sept. 30.

Related News Articles

Headline
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
The House Energy and Commerce Subcommittee on Health Sept. 10 advanced the Title VIII Nursing Workforce Reauthorization Act (H.R. 3593), AHA-supported…
Headline
The House Appropriations Committee Sept. 9 advanced the fiscal year 2026 appropriations bill for the Departments of Labor, Health and Human Services, Education…
Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Headline
The AHA Sept. 4 expressed support for the Hospitals As Naloxone Distribution Sites Act (H.R. 5120), legislation that would require Medicare and Medicaid to…
Headline
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain…